Navigation Links
PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
Date:1/23/2012

regarding future results and events, including, without limitation, statements regarding expected financial results, future growth and customer demand.
For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements.  Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "will," "would," "could," "should,"  "targets," and similar expressions are also intended to identify forward-looking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, including the anticipated additional restructuring charges of approximately $4 million in the second quarter of Fiscal Year 2012; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of h
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
2. PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
3. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
4. UCB and PAREXEL Sign Strategic Partnership Agreement
5. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
6. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
7. PAREXEL Reports First Quarter Fiscal Year 2012 Financial Results
8. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
9. New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership
10. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
11. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014 In today,s increasingly ... web presence to reflect the needs of a ... must meet the needs of key stakeholders while ... According to recent research by benchmarking ... the participating companies averaged more than $100,000 in ...
(Date:12/19/2014)... 2014 Radiology information system ... used to store, manipulate, and distribute patient radiological ... tracking and scheduling system, result reporting, and an ... HIS and other databases improves the hospital workflow. ... scheduling, patient list management, radiology department workflow management, ...
(Date:12/19/2014)... Dec. 18, 2014  Decision Resources Group finds that ... States will increase to a value of ... driven by expansion in the large direct energy device ... be increasingly adopted due to the advantages they offer ... key findings from Decision Resources Group,s coverage of the ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3
... Precision and Reduce High Failure Rates in Central ... 16 ICON (Nasdaq: ICLR ) ... to the pharmaceutical, biotechnology and medical device industries ... patient evaluation, today announced that they have signed ...
... Patients on corticosteroids are one-third less likely to ... taking statin medicationsStudy is first in a series ... medicationsFRANKLIN LAKES, N.J., March 14 Results of ... Meeting of the American Academy of Asthma, Allergy ...
Cached Medicine Technology:ICON and MedAvante Sign Alliance Agreement 2New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 2New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 3New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 4
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called the ... In the promotion, all buyers worldwide can enjoy a ... special for the women who are looking for inspired, ... collections of 2015 dresses have been unveiled recently. All ... prices. Visit our website now before they are out ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Today, Balfleet.com, ... announces a Christmas Sale, offering 50%-70% off on its ... holiday season. , The mother of the bride dresses ... The company is 24/7 accessible and takes pride in ... delivery. , “We are offering great discounts on our ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Energy ... Bedsheets are now available. Celliant, the world’s leading ... sheets and pillowcases. , There are a number ... additional circulation, increased oxygenation and balanced body temperature; ... healing and pain relief; enhanced athletic performance; and ...
(Date:12/19/2014)... Albany, NY (PRWEB) December 20, 2014 ... Africa, Russia, and other nations. Around 151,000 tons of ... on year. The global vanadium usage increased at 6.7% ... which, the steel and iron industry, being the largest ... industry in 2013, followed by titanium-vanadium alloy and the ...
(Date:12/19/2014)... The intestinal bacteria that cause inflammatory bowel disease, which ... researchers report. The findings, published recently in the ... to prevent the disease and treat the 1.6 million ... "The intestinal bacteria, or ,gut microbiome, you develop ... impact on your health for the rest of your ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2
... men who are exposed to pesticides that is used for ... developing Parkinson’s disease //. ,Parkinson's disease is a disorder ... so may affect movement, speech and posture. ,Mayo ... developed Parkinson's disease between 1976 and 1995. ,Men ...
... men suffer, is thankfully out of the closet. After ... men are finding solutions to their problem. ... dysfunction, it is increasingly important for clinicians in a ... mechanisms and systemic effects of these medications,” said Ernst ...
... curing medicine have been found by researchers at the ... and Therapeutics (CMMT), when they studied with mouse. This ... ,Published today in Cell journal, Dr. Michael Hayden ... the mutant huntingtin protein responsible for Huntington disease (HD) ...
... zoo official has alleged that the San Francisco Zoo had ... disease for an exhibit encouraging human interaction //. ... lovers are concerned that the virus which causes psittacine beak ... The ailment can attack a bird's immune system causing abnormal ...
... health minister Andy Kerr has ordered the closure of two ... to close the hospitals in the border as part of ... of the 80-year-old nine-bed Queen Margaret Hospital in Jedburgh and ... towns worked hard to save the community hospitals. The Jedburgh ...
... Health Minister Philippe Couillard on Thursday that would give Quebecers ... Supreme Court of Canada decision had partially struck down Quebec's ... had failed to prove its ban on private health insurance, ... the development of Bill 33, proposed by Couillard, people can ...
Cached Medicine News:Health News:Host of Benefits from Erectile Dysfunction Drugs 2Health News:Host of Benefits from Erectile Dysfunction Drugs 3Health News:Animal Study Found Cure For Huntington Disease 2Health News:Quebecers To Choose Private Health-Care Insurance 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0540, 0887....
Enzyme Immunoassay of D-Dimer by ELISA Method, 96 tests....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products: